Augmented teicoplanin clearance through probable adsorption onto a polymethyl methacrylate (PMMA) hemofilter during continuous venovenous hemodiafiltration

J Infect Chemother. 2020 Sep;26(9):992-994. doi: 10.1016/j.jiac.2020.04.001. Epub 2020 Apr 22.

Abstract

Teicoplanin, a glycopeptide antibiotic against Gram-positive bacteria, is used during continuous venovenous hemodiafiltration (CVVHDF), though adsorption onto a hemofilter has been observed in an in-vitro study. We report a case of extensive augmentation of teicoplanin clearance by a polymethyl methacrylate (PMMA) hemofilter. A 74-year-old man (body weight 53 kg) was performed CVVHDF with the PMMA hemofilter. The effluent flow rate maintained at 600-650 mL/h. The measured teicoplanin clearance was 31.0 mL/min, and the clearance was reduced to 11.1 mL/min over the next 6.5 hours. In conclusion, we should closely monitor teicoplanin dosing during CVVHDF using a PMMA membrane hemofilter.

Keywords: Adsorption; Continuous venovenous hemodiafiltration; Hemofilter; Polymethyl methacrylate; Teicoplanin.

Publication types

  • Case Reports

MeSH terms

  • Adsorption
  • Aged
  • Continuous Renal Replacement Therapy*
  • Hemodiafiltration*
  • Humans
  • Male
  • Polymethyl Methacrylate
  • Teicoplanin

Substances

  • Teicoplanin
  • Polymethyl Methacrylate